missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ NY-BR-1 Polyclonal Antibody

Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA5101251
This item is not returnable.
View return policy
Description
Antibody detects endogenous levels of total AN30A.
NY-BR-1 is a novel differentiation marker predominantly expressed in normal breast and breast cancer. It has been shown by Immunohistochemistry (IHC) that NY-BR-1 was present solely in ductal epithelium of normal breast tissue. Invasive carcinoma of the breast and carcinoma in situ were positive for NY-BR-1, whereas most other tumors and normal tissues are negative, with the exceptions of one-third of sweat gland carcinomas and around two percent of prostate carcinoma. NY-BR-1 is reported to express more frequently in estrogen-positive and lymph node-negative primary carcinomas, and more commonly in grade 1 than in grade 2 or grade 3. In a study by Varga et al (2006) forty-nine percent of lymph node metastasis were shown to be positive.
Specifications
| NY-BR-1 | |
| Polyclonal | |
| Unconjugated | |
| ANKRD30A | |
| ANKRD30A; ankyrin repeat domain 30A; ankyrin repeat domain-containing protein 30A; breast cancer antigen NY-BR-1; NY-BR-1; serologically defined breast cancer antigen NY-BR-1 | |
| Rabbit | |
| Affinity chromatography | |
| RUO | |
| 91074 | |
| -20°C | |
| Liquid |
| Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
| 1 mg/mL | |
| PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 | |
| Q9BXX3 | |
| ANKRD30A | |
| A synthesized peptide derived from human ANKRD30A(Accession Q9BXX3), corresponding to amino acid residues H1102-L1152. | |
| 100 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction